Diagnosis and Evaluation of Iron‑Deficiency Microcytic Anemia

1. Clinical Presentation and Initial Laboratory Findings

• Microcytic hypochromic anemia is most commonly caused by iron deficiency, with thalassemia, anemia of chronic disease, and sideroblastic anemia as important differentials【1】【2】.
• A hemoglobin level of ~10.7 g/dL confirms the presence of anemia【3】.
• Mean corpuscular volume < 80 fL (e.g., 79 fL) defines microcytosis【1】【2】.
• Low mean corpuscular hemoglobin (≈24 pg) indicates hypochromia【3】.
• The combination of microcytosis and hypochromia strongly points to iron‑deficiency anemia【1】【2】【4】.

2. Serum Ferritin as the Primary Iron‑Status Test

• Serum ferritin is the single most powerful test for diagnosing iron deficiency【5】【6】【7】.
• Ferritin < 12 µg/L is diagnostic of iron deficiency regardless of inflammatory status【5】【6】【7】.
• In the absence of inflammation, ferritin < 30 µg/L confirms iron deficiency【8】【4】【9】.
• Ferritin 30–100 µg/L may still indicate iron deficiency when inflammation is present【8】【4】【9】.
• Ferritin > 100 µg/L essentially excludes iron deficiency【5】【6】.

3. Assessing Inflammation

• Inflammatory markers (CRP, ESR) should be measured because inflammation can falsely elevate ferritin, masking iron deficiency【8】【4】.
• With inflammation, ferritin up to 100 µg/L can still represent iron deficiency【8】【4】【9】.
• Transferrin saturation < 20 % together with ferritin 30–100 µg/L suggests combined iron deficiency and anemia of chronic disease【9】.

4. Differentiating Thalassemia Trait

• Thalassemia trait also produces microcytic anemia but typically shows normal or elevated ferritin and an increased red‑cell count【1】【5】【6】.
• Hemoglobin electrophoresis is recommended when ferritin is normal/high or when the patient belongs to an ethnic group with high thalassemia prevalence【1】【3】.
• In thalassemia, the reduction in MCV is disproportionate to the degree of anemia【3】.

5. Reticulocyte Index and Additional Iron Indices

• A reticulocyte index < 2.0 indicates reduced red‑cell production, compatible with iron deficiency, vitamin deficiencies, or marrow dysfunction【1】【2】.
• Normal or low reticulocyte counts in microcytic anemia further support iron deficiency, anemia of chronic disease, or hereditary causes【8】【4】.
• Transferrin saturation < 15–20 % reinforces the diagnosis of iron deficiency【1】【2】【10】.
• Elevated red‑cell distribution width (RDW) is a useful clue for iron deficiency and for detecting combined deficiencies【8】【5】【6】.
• Total iron‑binding capacity (TIBC) is typically increased in iron deficiency【1】【2】.

6. Common Pitfalls to Avoid

• In adults, gastrointestinal blood loss—not merely dietary insufficiency—is the most frequent cause of iron deficiency and warrants investigation【5】【6】【7】.
• Concurrent folate or vitamin B12 deficiency can normalize MCV, masking microcytosis; an elevated RDW helps uncover mixed deficiencies【5】【6】.
• Because ferritin is an acute‑phase reactant, it may appear normal in iron‑deficient patients with concurrent inflammation, malignancy, or liver disease【8】【5】【4】【6】.
• Failure to perform hemoglobin electrophoresis in high‑risk ethnic groups can miss thalassemia trait, leading to inappropriate management【1】【3】.

7. Therapeutic Trial as a Diagnostic Tool

• A rapid hemoglobin rise of ≥10 g/L within 2 weeks after oral iron therapy is highly suggestive of absolute iron deficiency, even when iron studies are equivocal【3】.
• This therapeutic trial can serve both as diagnostic confirmation and as the initial treatment for iron‑deficiency anemia【5】【6】.

Guidelines for Diagnosis and Management of Iron‑Deficiency Anemia (IDA)

Diagnostic Criteria and Laboratory Evaluation

• A low mean corpuscular volume (< 80 fL) together with reduced hemoglobin confirms microcytic anemia, a hallmark of IDA. 11, 12
• Serum ferritin is the most powerful single test for diagnosing IDA and should be measured in all suspected cases. 13, 11
• Ferritin < 12 µg/L is diagnostic of iron deficiency irrespective of the presence of inflammation. 11
• Ferritin < 30 µg/L in the absence of inflammation confirms iron deficiency. 14, 11
• Ferritin 30–100 µg/L together with elevated inflammatory markers (CRP or ESR) may still indicate iron deficiency. 14, 11
• Ferritin > 100 µg/L essentially excludes iron deficiency. 13, 11
• Concurrent measurement of CRP or ESR is required because inflammation can falsely raise ferritin levels, masking underlying iron deficiency. 11
• A low‑normal reticulocyte count supports IDA by indicating an inadequate marrow response to anemia. 11
• Peripheral blood smear showing microcytic, hypochromic “pencil‑cell” erythrocytes reinforces the diagnosis of IDA. 14

Treatment Recommendations

• Oral iron supplementation at 3–5 mg/kg/day for 12 weeks is the first‑line therapy; treatment should be continued for an additional three months after hemoglobin normalization to fully replenish iron stores. 14
• When oral iron is not tolerated, intravenous iron administered in pulsed doses is recommended. 15, 16

Investigation of Underlying Causes

• In adult men and post‑menopausal women, occult gastrointestinal (GI) blood loss is the most common cause of IDA; therefore, upper and lower GI endoscopy should be performed to exclude occult malignancy (e.g., gastric or colonic cancer). 13
• Celiac disease serology should be obtained to assess for malabsorption as a contributing factor. 14, 13
• A detailed history of non‑steroidal anti‑inflammatory drug (NSAID) use is essential because NSAIDs are a frequent source of occult GI bleeding. 14, 13
• Stool testing for occult blood and parasites (e.g., hookworm in endemic regions) should be included in the work‑up. 13
• In pre‑menopausal women, menstrual blood loss is the predominant cause, but GI evaluation remains indicated when anemia is severe or refractory to therapy. 13

Monitoring and Follow‑Up

• Re‑assessment of ferritin and transferrin saturation after hemoglobin has returned to normal is required to confirm iron repletion. 15, 16

Key Pitfalls to Avoid

• Do not omit ferritin measurement; it cannot be replaced by other iron indices. 13, 11
• Do not disregard concurrent inflammation; ferritin values up to 100 µg/L may still reflect iron deficiency when CRP is elevated. 14, 11
• Do not neglect investigation for GI blood loss in adults, as it may uncover occult malignancy. 13
• Do not perform repeated phlebotomies in patients with IDA, as this can further deplete iron stores. 15, 16

Diagnostic Evaluation and Management of Iron‑Deficiency Anemia in Patients with Daily Alcohol Use

Laboratory Findings that Indicate Iron Deficiency

• Reduced red‑cell indices—mean corpuscular volume ≈ 82.7 fL, mean corpuscular hemoglobin ≈ 24.9 pg, and mean corpuscular hemoglobin concentration ≈ 30.1 g/dL—are consistent with iron‑deficiency anemia in adults presenting with microcytic‑hypochromic anemia (NCCN). 17, 18

Iron‑Deficiency Confirmation Tests

• A transferrin saturation < 15 % together with a serum ferritin < 30 µg/L confirms absolute iron deficiency, even when inflammation may be present (NCCN). 17, 18
• A reticulocyte index < 2.0 indicates decreased erythropoietic output and supports iron‑deficiency anemia (NCCN). 17, 18

Additional Investigations Recommended by Guidelines

• Stool guaiac testing should be performed to detect occult gastrointestinal bleeding as a potential source of iron loss (NCCN). 17
• A comprehensive metabolic panel is advised to evaluate liver function beyond isolated AST/ALT values in patients with chronic alcohol intake (NCCN). 17
• Serum magnesium and phosphate levels are commonly depleted in chronic alcohol users and should be checked (NCCN). 17

Alcohol‑Related Hematologic Effects

• Chronic alcohol consumption can cause macrocytosis that masks underlying microcytosis when combined nutrient deficiencies are present (NCCN). 18

Alcohol Cessation Counseling

• Daily alcohol use contributes to anemia through gastrointestinal blood loss, malabsorption, marrow suppression, and nutritional deficiencies; referral to addiction services is recommended (NCCN). 18